This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (4558)
-
December 16, 2025 | Insight Sanofi's second medical use patent revoked by UPC in win for generics
Sections: Intellectual Property
-
December 16, 2025 | Insight China launches self-check campaign to curb certificate-lending in patent agency industry
...China has launched a nationwide crackdown on misconduct in the intellectual property services sector,...
Sections: Intellectual Property
-
December 15, 2025 | Official Statement US judge rules for OpenAI, says robots.txt files don't control access to web content
Sections: Artificial Intelligence and Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login